2C and insert in 2D). At 48 h, an inflammatory infiltrate was observed in the medullar region of the kidneys (Fig. 2D). Marked diffuse congestion and erythrophagocytosis were observed in the spleens at 6 h, whereas large aggregates of hemosiderin engulfed macrophages were noted at 48 h (Fig. 2E and F). The lungs displayed intense hemorrhaging, which was evidenced by the presence of abundant erythrocytes in the bronchiolar and alveolar spaces mainly at 6 h. Lung sections also demonstrated
mixed inflammatory infiltrate of polymorphonuclear and mononuclear cells that dilated the alveolar septa (48 h), edema in the pulmonary parenchyma and perivascular edema (12 h) (Fig. 3). No morphological changes were observed in the liver, this website brain and cerebellum at any of the time points evaluated. After 96 h of envenomation, all organs displayed normal morphology. The animals in the control group (those that had check details been injected with PBS) exhibited no alterations at all. The myotoxicity of L.
obliqua venom was evaluated both in vivo ( Fig. 4) and in vitro ( Fig. 5) by measuring the release of creatine-kinase (CK) and its cardiac isoform, creatine-kinase-MB (CK-MB), and was also evaluated by morphological examination. After subcutaneous injection of LOBE (1 mg/kg), the rats displayed high levels of serum CK, which was the first evidence of skeletal muscle damage. At 12 h, serum CK activity had increased 20-fold, reaching levels 40 times higher than control values at 48 h ( Fig. 4A). There was also a significant increase in serum CK-MB activity, which reached a maximum at 12 h (53.6 ± 7.5 U/L) as compared to the control group (5.8 ± 0.4 U/L), indicating that cardiac damage had occurred. These values remained elevated at 24 h (45.6 ± 3.4 U/L) and 48 h (40.0 ± 0.9 U/L) ( Fig. 4B). Heart histopathological
analyses confirmed the cardiotoxicity of the venom. Necrosis of cardiomyocytes was associated with inflammation and myocardial hemorrhage between 6 and 48 h ( Fig. 4C–E). To investigate a possible direct myotoxic effect of the LOBE, an isolated muscle preparation was used. As shown in Fig. 5A, when two different concentrations of the LOBE were added to the extensor Baricitinib digitorum longus (EDL) preparations, dose- and time-dependent increases in CK release rates were observed in comparison to the controls (EDL treated with PBS). This result indicated that the venom has specific myotoxins that are able to act directly on muscle cells, which confirms the data obtained systemically in envenomed rats. When compared with the snake venom from B. jararaca (a well characterized myotoxic venom), the LOBE presented a myotoxic activity that was approximately 32.6% lower at the same dose ( Fig. 5B). In addition, the previous incubation of the LOBE with antilonomic serum (ALS) resulted in a reduction of 70.6% in CK release rate from the EDL.